ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

LCP Lon.Asia China

13.00
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Lon.Asia China LSE:LCP London Ordinary Share GB00B0XF7K04 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 13.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

London Asia Chinese Private Eq.F Share Discussion Threads

Showing 26 to 50 of 225 messages
Chat Pages: 9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
08/9/2006
15:33
So here is how it looks

25% stake in China New Energy bought for £2.2m
M.cap at float = 35m.
LCP stake profit = 35*0.25 - 2.2 = £6.55m

31% stake in China Biofoods bought for £2.1m
M.cap at float = 12.5m
LCP stake profit = 12.5*0.31 - 2.1 = £1.775m

10% stake in Mobile Net bought for £96800
M cap at float = £7.5m
LCP stake profit = 7.5*0.10 - £96800= 0.6532m

So Paper profit on the week a mighty £8.9782 m

robsy2
06/9/2006
12:41
China biofoods now confirmed for listing tomorrow
boonboon
06/9/2006
11:28
Nice posts fellas and nice business for LDC and LCP.
It all bode well for us shareholders.

Looking at eth CNE float I see the directors have all awarded themselves lots of options. This should keep them interested as time goes on.

RE; CNE " LACPEF has invested GBP 2.2 million in the Company which equates to a
price of 127p per share.
650,000 options have been granted to directors and senior management to acquire
ordinary shares at 150p per share. A further 700,000 options have been granted
to directors and senior management to acquire ordinary shares at 525p per
share."

If they ever get to exercise them then we will all be laughing.
I remain bullish of the whole thing and especailly the warrants on the LCP fund see LCPW.

robsy2
06/9/2006
08:13
LCP have invested in 5 companies 2 of which have now listed with a 3rd expected any day now.

They invested £2million for a 19% stake in Dalian business institute which is now worth £3,354,013, based on the bid price.

They invested £1.9million for a 25% stake in China new energy which at listing had a value of £8,584,710 based on the bid price.

boonboon
06/9/2006
08:09
The latest RNS shows the following:

25% stake in China New Energy bought for £2.2m
M.cap at float = 35m.
LCP stake profit = 35*0.25 - 2.2 = £6.55m

31% stake in China Biofoods bought for £2.1m
M.cap at float = 12.5m
LCP stake profit = 12.5*0.31 - 2.1 = £1.775m

At float prices that they've just made £8.325 million. And that's discounting all the other things like price rising, divis, etc.

amitkoth
06/9/2006
07:23
China New Energy Limited select Overview Profile Contacts Reports & Accounts Offerings News Market Data Charts

News
China New Energy Limited - Start of trading


CHINA NEW ENERGY LTD

START OF TRADING

The Directors of China New Energy Limited ("CNE" or "the Company") are pleased
to announce that the Company's shares have commenced trading on PLUS today
under the sector classification Speciality and Other Finance. The total number
of ordinary 1p shares to be admitted to trading on PLUS is 6,733,106. The
opening price is expected to be 525p per share.

BUSINESS ACTIVITIES

CNE, a newly incorporated Jersey company, has been established as an investment
vehicle focusing on the rapidly expanding ethanol sector in China. The Company
is seeking to acquire operational assets relating to the supply of turnkey
technology solutions for the production of ethanol, edible alcohol and acetic
acid from a range of bio-resources, including corn, sugarcane, cassava and
other bio-resources in China. The Company aims to become a leading player in
China's fuel ethanol market by:

* Supplying equipment, engineering design, installation, and commissioning
of ethanol production equipment;
* After sales service for newly built and reformed factories;
* Ownership of ethanol production facilities.

The Directors have identified a number of opportunities which, in their
opinion, will meet the Company's investment strategy. The Company has raised
GBP 2.2 million from the London Asia Chinese Private Equity Fund ("LACPEF").

THE MARKET

Fuelled by rapid economic growth, China has become a significant energy
consumer, with its annual increase in energy consumption almost equal to the
total installed capacity in the UK, and usage rising by 16% alone in 2004.
Although China's oil consumption is the second highest in the world, it is
still less than a third of that of the US, and less than 10% per head of that
in the West. Demand growth in China accounted for 52% of global energy demand
growth from 2002-2004. In 2005, China imported over 44% of its oil consumption
and this is set to increase significantly as China's growth and manufacturing
boom continues.

The Chinese government is eager to reduce the country's reliance on oil imports
and to increase the uptake of alternative fuels, both for economic,
environmental and strategic defence reasons. It is therefore very supportive of
the renewable energy sector.

The Chinese government has enacted various laws and regulations encouraging the
use of renewable energy as a substitute for fossil fuels, one of which states
that vehicle fuel must comprise at least 10% fuel ethanol in 11 of the 33
provinces in China. This creates a new market for ethanol production, as
previously only one province was operating a trial system. As more provinces
start to implement this policy, China is likely to face a significant shortage
in fuel ethanol. According to the National Development and Reform Committee,
the demand for fuel ethanol in the next five years will reach 5-7 million
tonnes annually, whilst fuel ethanol production in 2005 was only 1.02 million
tonnes. Hence the market size is expected to increase considerably, resulting
in significant opportunities in the supply chain to the ethanol production
market.

FINANCIAL RESULTS AND SHAREHOLDERS

CNE was incorporated in Jersey in May 2006 and has minimal trading to date.

Significant shareholders are:

LACPEF 25.0%
Leader Vision Investment Limited 23.8%
(Beneficial owner - Yu Weijun)
Asia Tianxing Investment Limited 17.8%
(Beneficial owner - Tang Zhaoxing)
Best Full Investments Limited 17.8%
(Beneficial owner - Liang Hongtao)
Qiu Weiming 7.4%
Jiang Xinchun 7.4%

Directors' shareholdings in the Company are 41.6%.

LACPEF has invested GBP 2.2 million in the Company which equates to a
price of 127p per share.

650,000 options have been granted to directors and senior management to acquire
ordinary shares at 150p per share. A further 700,000 options have been granted
to directors and senior management to acquire ordinary shares at 525p per
share.

REASONS FOR LISTING

CNE is seeking to list its ordinary shares on PLUS in order to give it access
to the UK's capital markets to fund future expansion.

BOARD OF DIRECTORS

Mr Yu Weijun - Chairman
Mr. Yu, founder of the Company, is the former deputy chief of Guangzhou Energy
Institute of the China Academy of Sciences (CAS) the leading research centre in
China and has considerable experience in the fuel ethanol sector in China. Mr.
Yu is very experienced in the management of engineering companies, finance and
accounting. He has an EMBA from Sun Yat-sen University.

Mr Tang Zhaoxing - Executive Director
Mr. Tang is a Senior Engineer. He studied in the chemical faculty of the South
China University of Science & Technology. He is responsible for the development
and implementation of the technology for ethanol and its derived products,
equipment supply, technical services and R&D. He has 15 years experience in the
ethanol industry, and over 10 years experience in company management. He has an
EMBA from Peking University and a Master of Sciences.

Mr Simon Littlewood - Non-Executive Director
Simon is a co-founder and the Chief Executive of London Asia Capital plc
("London Asia"). After qualifying as a Chartered Accountant with Coopers &
Lybrand, London (now PwC) where he specialised in high growth companies, he
joined the structured and corporate finance division of the HSBC Group in
London. In 1995, he moved to BDO Stoy Hayward's corporate finance team, where
he advised on AIM flotations, mergers and acquisitions and fund raisings,
leaving in 1996 to set up the Temima Group, an investment and corporate finance
business. In 2002 he took over an AIM listed shell which he converted into
London Asia.

He has experience of working on transactions in the UK, Germany, Eastern
Europe, France, the US, Israel, China, Malaysia, Taiwan and Singapore. He is a
director of AIM listed Europasia Education plc and London Asia Chinese Private
Equity Fund, a number of private companies and represents London Asia on the
boards of several of its investee companies, including PLUS listed China
Education Group, China Eastsea Business Software and Peach Blossom Media. Simon
graduated in Law from Oxford University and is authorised by the UK's Financial
Services Authority.

Victor Ng - Non-Executive Director
Victor is a co-founder and executive director of London Asia Capital plc. A
former principal with KPMG Singapore, he has funded, advised and launched
several start-ups as well as later stage companies including several which were
subsequently listed in Singapore, Malaysia, New York and London.

Victor is currently a director of several China and Asia-Pacific-focused
companies including Singapore listed Asia Water and Asia Power Corp Limited, UK
AiM listed Europasia Education Limited and London Asia Chinese Private Equity
Fund, and PLUS traded China Education Group, Peach Blossom Media Limited, China
Biotech Healthcare limited and Dalian Business Institute.

RISK FACTORS

In addition to the usual risks associated with investing in small, high growth
businesses, the Company faces the following specific risks:

* The Company intends to invest, or make an acquisition, in the ethanol
industry in China. Consequently the Company's future prospects will be
dependent on commodity prices and the availability of raw material
supplies which are subject to significant volatility and uncertainty.

* The China ethanol industry is dependent upon a myriad of Chinese
government legislation and regulation and any adverse changes in
legislation or regulation could materially affect the Company's results,
operations and financial position.

* The Ordinary Shares will not be listed or dealt in on any stock exchange.
Notwithstanding the fact the Ordinary Shares are to be traded on PLUS,
this should not be taken as implying that there will be a "liquid" market
in the Ordinary Shares. An investment in the Ordinary Shares may thus be
difficult to realise. The value of the Ordinary Shares may go down as well
as up. Investors may therefore realise less than their original investment
or sustain a total loss of their investment.

* It may be necessary for the Company to raise additional capital to
progress through further stages of development. There can be no assurance
that such funding, if required, will be made available to the Company.

* The success of the Company will be dependent on the expertise and
experience of the Directors. The loss of one or more could have a
detrimental effect on the performance of the Company.

* The Company's operations will be based substantially in China through
subsidiary companies incorporated in China. Were there to be restrictions
imposed on the movement of currency out of China, or depreciation in the
Chinese currency, or a change in Chinese government, regulation or
policies, it could have a significant impact on the Company.

* The Company is incorporated in Jersey and has been granted tax exempt
status in this jurisdiction. The Directors intend to maintain this status.
Should any tax authority challenge this status the Directors intend to
defend the Company's tax position. However, a successful challenge may
result in the Company's profits being subject to applicable tax, which may
be at a higher rate payable than under its current status.

CORPORATE ADVISOR AND CONTACT DETAILS

London Asia Corporate Finance Limited is acting as the Corporate Advisor for
China New Energy Limited and can be contacted at:

Stephen Lucas
4th Floor, 35 Park Lane
London W1K 1RB
Tel 020 7355 7928
Fax 020 7495 1691
Email: stephen.lucas@londonasia.com

For additional information, visit the Company's web site at
www.chinanewenergygroup.com

Registered office:
Ordnance House
31 Pier Road
St Helier
Jersey, Channel Islands
JE4 8PW

The Directors of China New Energy Limited accept responsibility for this
announcement.

DIRECTORSHIPS

DIRECTOR CURRENT DIRECTORSHIPS PAST
DIRECTORSHIPS
Yu Weijun Guangdong Boluo Jiunen High & New
Technology Engineering Co., Ltd.
Guangzhou Zhongke Huangnen Science &
Technology Co., Ltd.
Guangzhou Zhongke Huayuan Science &
Technology Co., Ltd.
Guangdong Waste Environment Protection
Engineering Co., Ltd.
Guangzhou Ruipu Energy & Environmental
Science & Technology Co., Ltd.
Guangzhou Clean New Technology Co., Ltd.
Guangzhou Zhongke Water Environment
Protection Engineering Co., Ltd
Boluo Solid Waste Treatment Co., Ltd.
Leader Vision Investments Limited
Tang Zhaoxing Tongliao Zhongke Tianyuan Amylum Chemical
Co., Ltd
Huaiji Zhongke Tianlun Industrial Co.,Ltd.
Qinyuan Heli Huangnen Bio-engineering Co.,
Ltd
Asia Tianxing Investment Limited
Guangzhou Xinxing Tianyuan Investment Co.,
Ltd
Simon Littlewood London Asia Capital plc
Clean Technology plc
Europasia Education plc
Stunningview Ltd
Simolit Ltd
Temima Group plc
Chesterhigh Ltd
Outset Developments Ltd
Justproperty.com Ltd
China Education Group Ltd
China Eastsea Business Software Ltd
Peach Blossom Media Ltd
China Financial Services Inc
China Biotech Healthcare Ltd
Temima China Investment Banking Services
Co., Ltd
London Asia Chinese Private Equity Fund Ltd
China MobileNet Ltd
Victor Ng AEC. Edu Group Pte Ltd Metro-City
Asia Cable TV Pte Ltd Development
Asia Development Organisation Ltd Corporation Pte
Asia Power Corporation Ltd Ltd
Asia Water Technology Ltd Temima Singapore
Devotion Eco-Thermal Ltd Pte Ltd
Europasia Education Plc Technical
London Asia Capital Plc Training
London Asia Capital Ltd Institute
Mercur Business Control Asia Pte Ltd Australia
The Nanyang Insurance Company Ltd
Temima China Investment Banking Services
Co., Ltd
Temima Group Plc
Savant Infocomme Pte Ltd
Shandong Yuancheng Cable TV Co. Ltd
China Financial Services Inc
China Education Group Limited
China Biotech Healthcare Ltd
Peach Blossom Media Limited
Dalian Business Institute Ltd
London Asia Chinese Private Equity Fund Ltd
China MobileNet Ltd

boonboon
01/9/2006
12:15
Thanks all for the great thread. Very informative.I have leapt in this morning and bought the warrants. I've never bought a warrant in my life before but they looked good value at 26p giving me a buying in price of 1.46p at any time before 31-3-11.I'll eat my socks if this stock doesnt hit that sometime over the next 5 years.
robsy2
22/8/2006
11:23
They've no changed it

Significant shareholders are:

Ru Ji 30%
Jianguo Zhang 20%
Aijun Wang 10%
Haipeng Fu 10%
London Asia Chinese Private Equity Fund Ltd 10%
Yan Xiong 8%
Wenshu Wang 7%
Genxi Li 5%

boonboon
22/8/2006
09:07
so LCP have 10 % of the 118 % of China BIO then, boonboon
portly2
21/8/2006
09:04
Here's the next one.

21 August 2006

CHINA NEW ENERGY LTD

APPLICATION ANNOUNCEMENT

The Directors of China New Energy Limited ("CNE" or "the Company") are pleased
to announce that the Company has applied to join PLUS via an introduction under
the sector classification Speciality and Other Finance. The expected date of
first trading is 6 September 2006.


BUSINESS ACTIVITIES

CNE, a newly incorporated Jersey company, has been established as an investment
vehicle focusing on the ethanol sector. The Company is seeking to acquire
operational assets relating to the supply of turnkey technology solutions for
the production of ethanol, edible alcohol and acetic acid from a range of
bio-resources, including corn, sugarcane, cassava and other bio-resources in
China. The Company aims to become a leading player in China's fuel ethanol
market by:


· Supplying equipment, engineering design, installation, and commissioning of
ethanol production equipment;

· After sales service for newly built and reformed factories;
· Ownership of ethanol production facilities.

The Directors have identified a number of opportunities which, in their opinion,
will meet the Company's investment strategy. The Company has raised GBP2.2
million from the London Asia Chinese Private Equity Fund ("LACPEF").


The Company has a strong and highly experienced management team. Mr. Yu Weijun,
Chairman, is the former deputy chief of Guangzhou Energy Institute of the China
Academy of Sciences, the leading research centre in China and has considerable
experience in the fuel ethanol sector in China. He has an EMBA from Sun Yat-sen
University.


Mr. Tang Zhaoxing, Executive Director, is a Senior Engineer and studied in the
chemical faculty of the South China University of Science & Technology. He has
15 years experience in the ethanol industry, including 10 years experience in
company management, and is currently responsible for the development and
implementation of the technology for ethanol and its derived products, equipment
supply, technical services and R&D. He has an EMBA from Peking University and a
Master of Sciences.


Simon Littlewood and Victor Ng, Executive Directors of LACPEF, have joined the
Company's board as non executive directors to assist in the development of the
Company.



THE MARKET

Fuelled by rapid economic growth, China has become a significant energy
consumer, with its annual increase in energy consumption almost equal to the
total installed capacity in the UK, and usage rising by 16% alone in 2004.
Although China's oil consumption is the second highest in the world, it is still
less than a third of that of the US, and less than 10% per head of that in the
West. Demand growth in China accounted for 52% of global energy demand growth
from 2002-2004. In 2005, China imported over 44% of its oil consumption and this
is set to increase significantly as China's growth and manufacturing boom
continues.


The Chinese government is eager to reduce the country's reliance on oil imports
and to increase the uptake of alternative fuels, both for economic,
environmental and strategic defence reasons. It is therefore very supportive of
the renewable energy sector.


The Chinese government has enacted various laws and regulations encouraging the
use of renewable energy as a substitute for fossil fuels, one of which states
that vehicle fuel must comprise at least 10% fuel ethanol in 11 of the 33
provinces in China. This creates a new market for ethanol production, as
previously only one province was operating a trial system. As more provinces
start to implement this policy, China is likely to face a significant shortage
in fuel ethanol. According to the National Development and Reform Committee, the
demand for fuel ethanol in the next five years will reach 5-7 million tonnes
annually, whilst fuel ethanol production in 2005 was only 1.02 million tonnes.
Hence the market size is expected to increase five fold, resulting in
significant opportunities in the supply chain to the ethanol production market.




FINANCIAL RESULTS AND SHAREHOLDERS

CNE was incorporated in Jersey in May 2006 and has minimal trading to date.

Significant shareholders are:

Leader Vision Investment Limited 24%
Asia Tianxing Investment Limited 18%
Best Full Investments Limited 18%
Qiu Weiming 7%
Jiang Xinchun 7%
LACPEF 25%

The Directors of China New Energy Limited accept responsibility for this
announcement.


London Asia Corporate Finance Limited is acting as the Corporate Advisor for
China New Energy Limited, and can be contacted at:


Stephen Lucas
4th Floor, 35 Park Lane
London W1K 1RB
Tel 020 7355 7928
Fax 020 7495 1691
Email: info@londonasiacf.com

boonboon
21/8/2006
07:45
China Biofoods Limited
Type of Issue: Introduction

CHINA BIOFOODS LIMITED

APPLICATION ANNOUNCEMENT

The Directors of China Biofoods Limited ("China Biofoods" or "the Company")
are pleased to announce that the Company has applied for admission to PLUS
under the Health sector classification. The expected date of first trading is
6 September 2006.

BUSINESS ACTIVITIES

China Biofoods, registered in Jersey, is the holding company of Henan Yuanhua
Biotechnology Co., Ltd ("Yuanhua") based in Xuchang, Henan Province, the
centre for farming traditional Chinese medical herbs. It specialises in the
production of highly purified herb extract products, which are then used to
produce traditional Chinese medicine, and as ingredients in functional foods.

The market for "Functional Foods" - foods or dietary components that may
provide a health benefit beyond their basic nutritional value - is expanding
rapidly worldwide, especially in China.

China Biofoods' core products are highly purified linolenic acids, Reshi
mushroom spore oil and deodorized garlic oil, which collectively account for
approximately 90% of its revenue.

Produced from the purification of extracts from plant seeds, linolenic acids
are extremely useful for healing and maintaining good health, but cannot be
produced by the human body. Proven functions of linolenic acid include
improving hair and skin, reducing blood pressure, helping prevent arthritis,
lowering cholesterol and triglycerides and reducing the risk of blood clots.
Highly purified linolenic acid is difficult for mass production due to its
fragility when exposed to air during the production procedure. It accounts for
nearly 50% of the Company's revenue and profit. According to an industry
report, the market has an annual average growth rate of 10%. China Biofoods
has a 25% market share in China for providing this product.

Reshi is widely accepted in oriental cultures as a precious herb for
strengthening the immune system. Scientific studies have showed strong
anti-viral and anti-oxidant effects. Since reshi spore is the most active
compound, reshi mushroom spore oil is broadly used in the health food industry
as a supplement and intermediate ingredient.

Garlic is a standard food supplement but normal garlic oil has an unpleasant
flavour, which limits its applications. China Biofoods developed the
technology to produce deflavoured garlic oil while maintaining all active
compounds in garlic.

The Company is in the process of launching a new product - high protein corn -
and has formed an alliance with the world famous biotech research team led by
Professor Niu Man Chiang, a Chinese American and world famous biologist. He
graduated from Beijing University and obtained the PhD from the University of
Stanford. He was awarded the 'American Man of Science', the Guggenheim Prize
and the Lily Prize for his outstanding research in the bio-science arena. He
is the founder of the 'Theory of Epigene'.

His team developed a patented high protein corn which, because of its high
nutritional and economic value, is believed to be the best choice for
poverty-alleviation projects in China.

In November 2005, Mr. Niu authorised China Biofoods to be the sole company
breeding his patented high protein corn in China. The corn is integrated with
soybean protein to deliver 4 times more protein than that of ordinary corn. It
thus serves as a much better protein source for the feed meal and food
industries. Mr. Niu is currently setting up a research centre within the
Company to provide technical support for this new project implementation.


KEY ASPECTS

· Strong research and development capability and patented technology:
· One of the few technology leaders in the industry, with 6 technology
patents
· Alliance with world famous biotech research team led by Professor Niu Man
Chiang and leading Chinese Universities;
· Existing range of health products in growing market:
· 25% market share in market growing 10% pa (linolenic acids)
· The first supplier of de-flavoured garlic oleoresin in China
· Strong customer base
· Well-developed sales network covering major cities in Greater China;
· Strategic partnership with leading pharmaceutical companies;
· New product pipeline - high protein corn;
· Close to high quality raw materials farming base and partnership with
herb planting farms;
· Experienced management team


THE MARKET

The rapid growth of functional foods in China is due to the convergence of
several factors.

· It is being used by the government as a means to tackle malnutrition in
underdeveloped, poverty-stricken regions of China. To address this problem,
the Centre for Public Nutrition and Development of China, a
government-sponsored institution, has in recent years proposed that some
necessity foods should be fortified. The high-protein corn project being
launched by China Biofoods is aiming to capture this opportunity.

· Dietary problems have arisen as living standards have improved in the
more developed parts of the country, especially in cities where consumers eat
an increasingly unbalanced diet and have hectic, yet sedentary lifestyles with
little time to exercise. The development of functional foods, like linolenic
acid products, provides consumers with the opportunity to have a more balanced
and nutritious diet. Currently, the key consumers of fortified and functional
products are city dwellers living in such places as Shanghai and Guangzhou, as
they tend to have higher nutrition awareness and greater media exposure to
wellness products.

· Consumer education in health and nutrition, coupled with increasing
purchasing power, is expected to significantly contribute to the growth of the
health foods market in general and the functional foods market in particular.

· Ageing population.

Affluent consumers in China and Hong Kong are increasingly looking for
functional foods as a means to counter illnesses and increasing healthcare
costs arising from unhealthy lifestyles and unbalanced diets, and longer life
expectancy.


FINANCIAL RESULTS AND SHAREHOLDERS

China Biofoods was incorporated in Jersey in April 2006 so has minimal trading
to date.

The proforma results for Yuanhua to December 2005, which assumes that China
Biofoods had been running the business for the 12 months then ended, shows
turnover of GBP2.9 million and profits after tax of GBP1.1 million.

Significant shareholders are:

Ru Ji 30%
Jianguo Zhang 24%
Aijun Wang 24%
Haipeng Fu 10%
London Asia Chinese Private Equity Fund Ltd 10%
Yan Xiong 8%
Wenshu Wang 7%
Genxi Li 5%


The Directors of China Biofoods Limited accept responsibility for this
announcement.

London Asia Corporate Finance Limited is acting as the Corporate Advisor for
China New Energy Limited, and can be contacted at:

Stephen Lucas
4th Floor, 35 Park Lane
London W1K 1RB
Tel 020 7355 7928
Fax 020 7495 1691
Email: info@londonasiacf.com

boonboon
25/7/2006
10:57
"In March we listed the London Asia Chinese Private Equity Fund ("the Fund") on
AiM (code LCP), raising the full #50 million it was seeking. The Fund focuses on investments in private Chinese businesses, and has to date committed to make
five investments, totalling #9.3 million, with another ten transactions
currently going through final due diligence."

from the LDC agm statement.

boonboon
30/6/2006
07:32
Acquisition

RNS Number:4253F
London Asia Chinese Private Equity
30 June 2006

30 June 2006

London Asia Chinese Private Equity Fund Limited

("LACPEF" or "the Fund")



Three new investments



LACPEF, the China focused investment fund, announces that it has committed to
make three new investments, for a total consideration of #6.9 million in cash.



The Fund is investing #1.9 million in China New Energy Ltd ("CNE"), a leading
turnkey provider of production equipment and technologies for ethanol production
in China; #2.9 million in China Synergy Real Estate Limited ("Synergy"), a
leading real estate services firm based in Beijing; and #2.1 million in China
Biofoods, a health food products company.



China New Energy:



CNE's core business is the supply of turnkey technology solutions for the
production of ethanol, edible alcohol and acetic acid from a range of
bio-resources, including corn, sugarcane, cassava and other bio-resources.



CNE has established itself as the leading brand in China, with an estimated 60%
share of the market for ethanol production equipment in China. The Company's
successful track record is key to growing the business and its leading
technology has been used in over 30 projects. CNE is supported by strong drivers
with the demand for ethanol, a fuel seen as an alternative to oil, still growing
and supported by a new legislative framework requiring 10% of all vehicle oil
consumption to be biofuel in 11 of China's Provinces.



For the year ended 31 December 2005 CNE reported profit after tax of #1.9m
(2004: #0.6m) on sales of #8.7m (2004: #3.1m). Based in Guangzhou, it was
founded in June 2002 as a spin-out from the Renewable Energy division of China's
Academy of Science, the leading Government funded centre in China for the
development of renewable energy technology.



CNE currently has 72 employees and following the investment from the fund, Simon
Littlewood and Victor Ng, managers of the Fund, will take a seat on the
Company's board.



China Synergy:



Synergy is the second largest real estate broker in the northern China market.
Founded 10 years ago in Beijing, China, the Company provides agency, consultancy
and conveyance services for property developers in China including international
property investors Carlyle Partners and Lehman Bros. The Company focuses on
deals with residential and commercial properties at the top end of the market,
and has advised on 60 projects.



Synergy was named as "Agency of the Year" in "New Real Estate", the industry
magazine, and in the Top 20 Real Estate Agencies in China" in 2005 by "SINA.com
".



For the year ended 31 December 2005 Synergy reported profit after tax of #2.1m
on turnover of #4.9m, up 58% and 38% respectively on 2004. Simon Littlewood
will be appointed to the Synergy Board following investment.



China Biofoods:



China Biofoods is based in Xuchang, Henan Province, the centre for farming
traditional Chinese medical herbs. It specialises in the production of highly
purified herb extract products which are then used to produce traditional
Chinese medicine, and as ingredients in functional foods.



The market for "Functional Foods" is expanding rapidly worldwide, especially in
China. "Functional Foods" are foods or dietary components that may provide a
health benefit beyond their basic nutritional value.



China Biofoods' core products are highly purified linolenic acids, Reshi
mushroom spore oil, and deodorized garlic oil. Linolenic acid, also known as
Vitamin F, is an essential fatty acid which is not produced by the body, and has
been proven to improve hair and skin, reduce blood pressure, help prevent
arthritis, lower cholesterol & triglycerides and reduce the risk of blood clots.
Reshi mushroom spore oil is broadly used in the health food industry as a
supplement and intermediate ingredient.



In 2005 China Biofoods reported revenues of #2.9m with profit after tax of
#1.2m. The Fund will appoint a representative to the China Biofoods Board
following investment.



Victor Ng, Director of LACPEF, commented: "All three companies presented at
London Asia's China Seminar in London earlier this month. There was strong
interest from investors as all three sectors are showing considerable growth on
the back of China's continued economic development. CNE is the leading player
in is field and has significant growth potential as China seeks to develop
renewable energy sources and reduce its reliance on expensive imported fossil
fuels. Synergy is taking advantage of the switch from public and subsidised
housing to the development of a private housing market in China, with the
Beijing market seeing additional impetus from the 2008 Olympics. China
Biofoods' products appeal to the increasingly affluent Chinese population, who
have more money to spend than in the past and are becoming more health
conscious, particularly as a result of the one child policy and the ageing of
the population"



Simon Littlewood, Director of LACPEF, added: "The Fund has now made five
investments, totalling #9.3 million. There is potential to make follow on
investments in those deals as the companies develop and we also have a number of
other deals which we expect to close in the near future."

For further information please visit www.londonasiafunds.com or contact:
John West/Matt Ridsdale Simon Littlewood Hugh Field
Tavistock Communications London Asia Capital plc Collins Stewart Limited
Tel: 020 7920 3150 Tel: 020 7355 7928 Tel: 020 7523 8000




This information is provided by RNS
The company news service from the London Stock Exchange
END

ACQFLMRTMMATBFF

boonboon
07/6/2006
07:28
One of it's first 2 investments Dalian business institute has now been floated on Ofex. The fund's 19% stake is now worth about £3.9million not bad considering they only paid £2million for it less than a month ago. Their second investment company Fsnet is due to float on ofex this month so hopefully we should see about the same return on that.
boonboon
03/6/2006
14:49
John Manser, Chairman, speaking at the London Asia China seminar on 14 June so should be some news then
painting
16/5/2006
21:21
15 May 2006
EUROPASIA EDUCATION

DBI Interim Results show strong growth

Europasia Education plc's ("EPE") investee company, Dalian Business Institute Ltd ("DBI"), today released interim results for the six months ended 31 January 2006 showing turnover of £1.0 million, and post tax profits of £0.9 million, up 13.1% on the comparative period in 2005.

DBI is a Jersey incorporated company with a 25 year contract for the management of Dalian Business Institute in Liaoning Province, China ("DBIC"). DBI is in the process of applying for admission to Ofex, with trading expected to commence on 23 May.

DBI announced last week that it had successfully raised £1.5 million to fund expansion of its facilities to meet demand for its courses. Following the fund raising, EPE's stake in DBI is 10.8%.

Mr Zhang Wenchao, President of DBIC, said: "We continue to see strong demand for our programs, reflected in the increased profits for the six months to January 2006. Once admitted to Ofex, we will look both to expand organically, through additional courses and increased facilities, and via acquisition, using the funds raised and the strong cash flows generated by the business."

James Holmes, EPE Chairman, said: "We invested £1.1 million for a stake in DBI, which should show a significant uplift when the company is admitted to Ofex in the next two weeks."

For further information, contact:


Paul Quade
City Road Communications
Tel 020 7248 8010 James Holmes
Europasia Education plc
Tel 020 7248 7578


About Dalian Business Institute China
DBIC is located in Dalian city, Liaoning Province. Founded in 1997, DBIC is a nationally accredited comprehensive three-year college focusing on business and arts subjects. There are currently over 5,000 students, based in the campus in Liaoning Province, China. There are 6 colleges and 5 faculties on the site, providing 3-year diploma and distance learning courses in 8 specific areas: Business Management; International Trade; International Accounting & Finance; Information Technology; International Tourism; Foreign Languages; Business Laws; and Arts.

The college diplomas awarded by DBI are recognised by the Ministry of Education (MOE), the government authority of China. In China, only a degree or diploma granted by a university or college accredited by the Ministry of Education can be recognised officially in the nation. DBI is also working with local renowned public universities, such as Bohai University & Dalian University of Technology, to provide additional 1-2 year courses leading to bachelor's degree from those partnership universities.

boonboon
11/5/2006
08:22
Been in this from the outset. Patiently waiting. I particularly liked the statements about more announcements to come. Sure they will since this was the whole point of the fund..........

"John Manser, Chairman of LACPEF said: 'Investor response to the fund has been strong and so it is particularly pleasing that we are announcing our first two
investments. The managers have sourced promising investment opportunities and we
look forward to announcing further investments in due course.'

Simon Littlewood, Executive Director of LACPEF, commented: 'Following the
raising of the Fund in March, we have spent the last six weeks finalising the
investment terms on a number of transactions for the Fund, with these the first
two to reach closure. Both are established, profitable businesses with good
growth prospects in expanding sectors in China.'"

silverthread
11/5/2006
08:09
The Dalian business institute deal could see a near instant return as it's planning to float on ofex in less than 2 weeks time.
boonboon
11/5/2006
08:04
i'm in this now for a small punt. The bulk of funds is in LDC, but they first 2 deals are hopefully the start of many and it should bring the fund to peoples attention. Both deals seem to be at around 5 x earnings which is really good.
boonboon
09/5/2006
12:16
I can easily see the net asset value of lcp increasing dramatically over 5 years. The warrants are interesting
gagner2006
09/5/2006
12:14
so lcp will need to be 150p for a profit

Yes, but obviously if the LCP price were 151 in five years, buying LCP would be better because the profit on LCPW is lower. There is a year 2011 price at which buying LCPW becomes more profitable than LCP per pound invested, possibly around 170 if some quick mental calculations are correct - I'd have to put the figures into a spreadsheet later to verify that. After that, the profits from LCPW grow exponentially more than an equivalent position LCP. The downside is they may expire worthless so the risk is much greater.

The warrants should follow the shareprice of LCP fairly closely, but there is an time decay factor as the expiry nears. Movements in LCPW of course, will be greater than LCP.

kamitora
09/5/2006
11:48
thx, found that. In effect warrants to 2011 to subcribe for lcp share at 120p, currently costing 30p so lcp will need to be 150p for a profit.

I think the warrants may follow the share price of lcp down, so a good investment but perhaps not immediately.

What do you think Kam??

gagner2006
09/5/2006
11:43
The LCP RNS I posted has a summary and the detail is on page 27 of the prospectus - there's a link to that in the header.
kamitora
09/5/2006
11:37
kam thx my system was going do lalley b4 when I typed in lcpw


got it now.

what are the broad terms of the warrants

gagner2006
09/5/2006
11:36
Yes, LCPW is the epic.
kamitora
Chat Pages: 9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock